参与尿素II诱导的腹腔肌细胞缩的信号通路
Hadeel S Al Ali1,2, Glenn C Rodrigo1, David G Lambert3
1Department of Cardiovascular Sciences, Clinical Sciences Wing, Glenfield Hospital, University of Leicester, Leicester, United Kingdom.
PloS one
|January 17, 2025
概括
尿二 (UII) 通过激活ERK1/2,p38和CaMKII通路,促进心脏缩. 抑制UII/UT受体系统可能有助于治疗心脏病并减少不良重塑.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 生理学 生理学 生理学
背景情况:
- 病理性心肌缩是心力衰竭 (HF) 的主要原因之一.
- 在HF中观察到循环中尿素II (UII) 水平升高,但其在缩发展中的作用尚不清楚.
- 尿素II (UII) 是一种涉及心血管功能的类激素.
研究的目的:
- 调查UII及其受体UT在心脏缩发展中的作用.
- 为了识别参与UII诱导心脏缩的信号分子.
主要方法:
- 隔离的成年大鼠心室肌细胞被用UII治疗.
- 通过测量长度/宽度比率来量化过度缩.
- 信号通路的激活 (ERK1/2,p38,CaMKII,JNK) 通过西测试进行评估.
- 测量了sarcoplasmic网膜 (SR) 的Ca2+-泄漏.
主要成果:
- UII治疗显著增加肌细胞缩 (L/W比率降低).
- UT-对手SB657510逆转了UII诱导的高.
- UII激活了ERK1/2,p38和CaMKII信号通路,这些通路对于增大至关重要.
- 没有观察到SR Ca2+泄漏的显著增加.
结论:
- 尿素II (UII) 通过MAPK和CaMKII信号传递促进心脏缩.
- 增加循环UII可能会导致左心室缩.
- 抑制UII/UT受体系统可能是心脏病治疗的治疗策略.
相关概念视频
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
378
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
378
Endocrine Signaling
63.9K
Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
63.9K
Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K


